An expert on premium research reports, Market Research Future predicts that Global tendinitis treatment market is expected to grow at the CAGR of ~3.8% during the forecast period and is estimated to reach USD 426.4 million by 2023. According to a recent study report published by the Market Research Future, the global tendinitis treatment market is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing USD 426.4 million with a constant CAGR during the anticipated period (2017 – 2023).
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3876
Tendinitis or Tendonitis is one of the common sports injuries and hence, it is more prevalent among athletes, especially tennis and golf players, among others. Moreover, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter’s syndrome or lupus account for the major risk factors leading to the occurrences of tendonitis.
Thanks to the technological advances transpired in the medical science that there are various pharmacological and non-pharmacological treatments available to manage the condition. With these multiple treatment options available., the tendinitis treatment market appears to be well-established and sorted.
The tendinitis treatment market in the Americas & Europe is accruing rapidly mainly due to the increasing aging population. Geriatric people owing to their low immunity levels or gene alteration are more prone to diseases such as arthritis, joint or bone pain, epilepsy, etc. Also, the spreading awareness among patients about the availability of novel treatments to manage this condition escalates the market on the furthered heights.
Key Players:
Key players leading the tendinitis treatment market in Americas & Europe include Pfizer (U.S.), Abbott (U.S.), AstraZeneca (U.K), Merck & Co. Inc. (Germany), Bayer (Germany), GlaxoSmithKline plc (U.S.), Boehringer Ingelheim Pharmaceuticals, Inc. (Germany), and Teva Pharmaceutical Industries (Israel) among others.
Industry/Innovation/Related News:
April 26, 2018 – Samumed, LLC (US), a leader in Wnt research and development presented its latest preclinical and clinical data on the company’s investigational Wnt pathway inhibitors for the treatment of osteoarthritis (SM04690) and tendinopathy (SM04755) at the 2018 Osteoarthritis Research Society International World Congress in Liverpool, U.K.
Segmentation:
Global tendinitis treatment market has been segmented on the basis of condition which comprises of tennis elbow, golfer’s elbow, pitcher’s shoulder, swimmer’s shoulder, jumper’s knee, and others.
On the basis of treatments, the market has been segmented into medications, therapy, surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids, Platelet-Rich Plasma (PRP), and others. Therapy is further sub-segmented into hot and cold therapy, physical therapy, occupational therapy, and others.
On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI) scans, and others.
On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Regional analysis
Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly includes North America and South America. Due to developed healthcare infrastructure and increasing R&D funding, US is dominating country in this region. Europe is second largest market for tendinitis treatment. Due to innovative product development and rapid adoption of new treatments, Germany is dominating this market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly changing healthcare sector, increasing awareness, and rising healthcare expenditure. Middle East and Africa is expected to have limited growth while Middle Eastern countries are expected to dominate this market during the forecast period.
Competitive Analysis
The market for tendinitis treatment is characterised by the presence of several well-established and small players, the global market of tendinitis treatment appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The tendinitis treatment market appears to be highly competitive owing to the presence of several large and small key players accounting for a substantial market share. Many leading players are concentrated in the Americas owing to well-established market and high healthcare expenditures; these players have expanded their market in other region as well. Furthermore, the companies such as Abbott, AstraZeneca, Teva, and Pfizer are well-established in European market. The major four players namely Abbott, AstraZeneca, Teva, and Pfizer accounted for more than 17% share of the Americas and Europe tendinitis market.
In April 2017, Pfizer entered into a merger with Allergan to gain access for Allergan’s portfolio including Botox, Viagra, the Prevnar pneumonia vaccine, and treatments for ailments including Alzheimer’s and rheumatoid arthritis.
Furthermore, in July 2017, Merck & Co.Inc & AstraZeneca entered into strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s LYNPARZA (olaparib) for multiple cancer types.
Furthermore, in November 2016, AstraZeneca announced a licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc., for the global rights to MEDI2070.
Moreover, May 2014, the company acquired Merck & Co., Inc.’s non-prescription business to become the OTC leader in North America and Latin America & achieve top global positions in key OTC product categories.
Therefore, the growing key business strategies will help the key competitors to expand their presence in various parts of the globe for their competitive products and will has spurred the growth of the market.
Browse Premium Research Report with Tables and Figures @ https://www.marketresearchfuture.com/reports/tendinitis-treatment-market-3876
Detailed Table of Contents:
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
11. Competitive Landscape
12. Company Profile
13. Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs Of The Market
13.2 Key Companies To Watch
13.3 Prediction Of Tendinitis Treatment Market
14. Appendix
…TOC Continued!
Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/3876
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
